Blepharo-cheilo-dontic syndrome

Known as: BCD SYNDROME, ECTROPION, INFERIOR, WITH CLEFT LIP AND/OR PALATE, Blepharocheilodontic syndrome 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2016
012319792016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Purpose:Blepharocheilodontic (BCD) syndrome is a rare autosomal dominant condition characterized by eyelid malformations, cleft… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Blepharo-cheilo-dontic (BCD) syndrome comprises the combination of lagophthalmia, euryblepharon, lower eyelid ectropion… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
The prooxidant effect of hydroxycinnamic acids (HCAs), i.e., caffeic acid (CaA), chlorogenic acid (ChA), sinapic acid (SA… (More)
Is this relevant?
2008
2008
Hemopexin (HPX) binds heme tightly, thus protecting cells from heme toxicity during hemolysis, trauma and ischemia-reperfusion… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2007
2007
The colorimetric Fe2+ indicators bathophenanthroline disulfonic acid (BPDS) and 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2… (More)
Is this relevant?
2004
2001
2001
The ability of metal chelating agents to prevent neuronal death caused by intra-hippocampal injections of cupric sulphate, ferric… (More)
Is this relevant?
2000
2000
Heme-hemopexin (2-10 microM) is used as a model for intravenous heme released in trauma, stroke, and ischemia-reperfusion. A… (More)
Is this relevant?
2000
2000
A model has been developed for the hemopexin receptor-mediated heme transport system based on iron uptake in yeast. Two steps are… (More)
Is this relevant?